02739-A: The Role of the Putative Tumor Suppressor Gene SETD2 in Canine Diffuse Large B-cell Lymphoma
Grant Status: Open
Lymphoma is a common, deadly cancer affecting both humans and dogs. Effective therapies without side effects are lacking. This study will investigate the role of a gene called SETD2 in the development of canine lymphoma. SETD2 is often disrupted in human cancers, including lymphoma, and preliminary data suggest a similar gene disruption in canine lymphoma. The work set forth will confirm alteration of this gene in dogs and evaluate whether and how it is related to clinical factors, including severity of disease, resistance to treatment, and dog breed. Overall, these studies will establish the significance of SETD2 dysfunction in canine lymphoma, laying the groundwork for future investigations to understand how this gene contributes to cancer development and how to more effectively treat canine lymphoma.
None at this time.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.